News >

 Roche prescribes ARM (04/02/2009)

Healthcare company Roche is using Active Risk Manager from Strategic Thought Group plc for its Group Risk Management. Roche selected Active Risk Manager following an evaluation of a number of risk management software products and the solution, installed in the company’s headquarters in Basel, is in the process of being rolled out.  

Roche has a robust system in place to identify and manage risks to its business.  Risk management has been mandated to Roche’s business units and employees.  Every business unit conducts a formal risk assessment process and develops risk management plans.  Active Risk Manager (ARM) supports this process and hence will become the common repository for group relevant risk information within Roche.  

Dominik Geller, Head of Corporate Risk Management at Roche said, “Enterprise Risk Management systems should provide a way of recording, prioritising and tracking the perceived risks over time across an organisation.  Active Risk Manager is already helping us to achieve this by allowing the analysis of risks using different metrics and with the proper security.”

Active Risk Manager, launched in 2001 as the first web-based enterprise risk management software system is currently in use by many of the world’s leading organisations including Lockheed Martin, NASA, Nestle and Network Rail in the UK.  

Martin Metcalf, Chief Executive Officer of Strategic Thought concluded, “Active Risk Manager provides a common standard for Enterprise Risk Management ensuring accountability and transparency across an organisation.  It helps to place key risks on the management agenda and allows for rigorous follow up and mitigation of those risks.  We are honoured to be working with a company that has pioneered many medical breakthroughs in its long history and look forward to continuing to support Roche through the continued implementation of its enterprise risk management processes.”


About Roche 

Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world’s biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people’s health and quality of life.

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2007 sales by the Pharmaceuticals Division totaled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested over 8 billion Swiss francs in R&D in 2007. Worldwide, the Group employs about 80,000 people.

Additional information is available www.roche.com.

About Strategic Thought Group plc

Strategic Thought is a leader in Enterprise Risk Management in both theory and practise through its team of industry practitioners who have a wealth of experience in setting enterprise-wide risk/reward strategies and implementing ERM programmes in a variety of industries.  

Active Risk Manager is the world’s leading web-based Enterprise Risk Management system.  ARM enables the identification, registration, communication, analysis and management of risks and opportunities.  ARM aids compliance with project, operational and enterprise-wide guidelines.  The effective management of risks and opportunities allows companies to act within corporate governance requirements and industry standards while balancing the risk/reward mix to maximise the return on opportunities.

Strategic Thought was founded in the UK in 1987 and opened offices in the US in 2004.  Active Risk Manager is used by many major organisations around the globe including BAE Systems, British Nuclear Group, Enbridge, Rio Tinto, Lockheed Martin, Nestle, NASA, London Underground, Raytheon and SABIC.